Last updated: July 12, 2022
Sponsor: National Cancer Institute (NCI)
Overall Status: Active - Recruiting
Phase
N/A
Condition
Telomere Related Diseases
Aplastic Anemia
Telomeres
Treatment
N/AClinical Study ID
NCT05436431
10000822
000822-C
All Genders
Study Summary
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:
- Diagnosed or being evaluated for a Telomere Biology Disorder (TBD) at a CCCTAA memberinstitution.
- Male or female, from 0 to 100 years.
Exclusion
EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participationin this study:
-Individuals who do not meet eligibility criteria. No other exclusionary criteria apply.
Study Design
Total Participants: 10000
Study Start date:
July 18, 2022
Estimated Completion Date:
December 31, 2037
Study Description
Connect with a study center
NIH National Cancer Institute - Shady Grove
Rockville, Maryland 20850
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.